Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Theorem Names Medical, Scientific Affairs VP | Contract Pharma
Breaking News, Promotions & Moves

Theorem Names Medical, Scientific Affairs VP

Rosenfeld to head Medical Device and Diagnostics Unit

Dr. Evan Rosenfeld has been appointed vice president of medical and scientific affairs, Medical Device and Diagnostics at Theorem Clinical Research. Dr. Rosenfeld has more than 10 years of experience in the medical device and diagnostic industries as both an attorney and medical director. Previously he served as medical director and senior consultant for regulatory and clinical affairs at Emergo Group Inc. During this time, he founded MDJD Consulting and worked as an independent consultant providing medical, clinical and regulatory analysis, insights and strategic recommendations. Dr. Rosenfeld also served as chief medical officer and senior vice president of regulatory affairs at Microtransponder Inc. and as chief medical officer and vice president of medical and regulatory affairs at Bioness Inc.
 
“Evan has a very dynamic background,” said John Potthoff, chief executive officer of Theorem Clinical Research. “He initially worked as a lawyer for medical device clients and then moved into chief medical officer roles within these companies after graduating from medical school. Evan understands this industry from both the legal and strategic leadership perspective, and he will be a great asset to our company.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters